News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
BioNTech and Pfizer have received a positive opinion from The Committee for Medicinal Products for Human Use (CHMP) for their updated COVID-19 vaccine, as a single dose for individuals 5 years of age and older, regardless of prior vaccination history, in...
Octave Bioscience, a precision care company advancing treatments for multiple sclerosis (MS), has announced the publication of the successful clinical validation of its multiple sclerosis disease activity (MSDA) test in the peer-reviewed journal Clinical...
EUROAPI and BianoGMP have signed a share purchase and transfer agreement under which EUROAPI will acquire 100% of Biano’s shares.